399 related articles for article (PubMed ID: 12568976)
1. Efficacy and tolerability of valerian extract LI 156 compared with oxazepam in the treatment of non-organic insomnia--a randomized, double-blind, comparative clinical study.
Ziegler G; Ploch M; Miettinen-Baumann A; Collet W
Eur J Med Res; 2002 Nov; 7(11):480-6. PubMed ID: 12568976
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double blind, placebo-controlled, prospective clinical study to demonstrate clinical efficacy of a fixed valerian hops extract combination (Ze 91019) in patients suffering from non-organic sleep disorder.
Koetter U; Schrader E; Käufeler R; Brattström A
Phytother Res; 2007 Sep; 21(9):847-51. PubMed ID: 17486686
[TBL] [Abstract][Full Text] [Related]
3. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality.
Donath F; Quispe S; Diefenbach K; Maurer A; Fietze I; Roots I
Pharmacopsychiatry; 2000 Mar; 33(2):47-53. PubMed ID: 10761819
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy and tolerability of Baldrian versus oxazepam in non-organic and non-psychiatric insomniacs: a randomised, double-blind, clinical, comparative study].
Dorn M
Forsch Komplementarmed Klass Naturheilkd; 2000 Apr; 7(2):79-84. PubMed ID: 10899744
[TBL] [Abstract][Full Text] [Related]
5. Effect of a fixed valerian-Hop extract combination (Ze 91019) on sleep polygraphy in patients with non-organic insomnia: a pilot study.
Füssel A; Wolf A; Brattström A
Eur J Med Res; 2000 Sep; 5(9):385-90. PubMed ID: 11003973
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study for assessing quality of life of patients with exogenous sleep disorders (temporary sleep onset and sleep interruption disorders) treated with a hops-valarian preparation and a benzodiazepine drug].
Schmitz M; Jäckel M
Wien Med Wochenschr; 1998; 148(13):291-8. PubMed ID: 9757514
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
8. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
Dorsey CM; Lee KA; Scharf MB
Clin Ther; 2004 Oct; 26(10):1578-86. PubMed ID: 15598474
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of modified-release indiplon in elderly patients with chronic insomnia: results of a 2-week double-blind, placebo-controlled trial.
Lydiard RB; Lankford DA; Seiden DJ; Landin R; Farber R; Walsh JK
J Clin Sleep Med; 2006 Jul; 2(3):309-15. PubMed ID: 17561543
[TBL] [Abstract][Full Text] [Related]
10. [Valerian as a sleeping aid?].
Pallesen S; Bjorvatn B; Nordhus IH; Skjerve A
Tidsskr Nor Laegeforen; 2002 Dec; 122(30):2857-9. PubMed ID: 12569707
[TBL] [Abstract][Full Text] [Related]
11. Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia.
Roger M; Attali P; Coquelin JP
Clin Ther; 1993; 15(1):127-36. PubMed ID: 8458042
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
Roth T; Soubrane C; Titeux L; Walsh JK;
Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of indiplon in older adults with primary insomnia.
Walsh JK; Moscovitch A; Burke J; Farber R; Roth T
Sleep Med; 2007 Nov; 8(7-8):753-9. PubMed ID: 17825616
[TBL] [Abstract][Full Text] [Related]
14. Validation of the sleep impact scale in patients with major depressive disorder and insomnia.
Lasch K; Joish VN; Zhu Y; Rosa K; Qiu C; Crawford B
Curr Med Res Opin; 2009 Jul; 25(7):1699-710. PubMed ID: 19505198
[TBL] [Abstract][Full Text] [Related]
15. Eight weeks of non-nightly use of zolpidem for primary insomnia.
Walsh JK; Roth T; Randazzo A; Erman M; Jamieson A; Scharf M; Schweitzer PK; Ware JC
Sleep; 2000 Dec; 23(8):1087-96. PubMed ID: 11145323
[TBL] [Abstract][Full Text] [Related]
16. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia.
Roth T; Walsh JK; Krystal A; Wessel T; Roehrs TA
Sleep Med; 2005 Nov; 6(6):487-95. PubMed ID: 16230048
[TBL] [Abstract][Full Text] [Related]
18. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
Roth T; Seiden D; Sainati S; Wang-Weigand S; Zhang J; Zee P
Sleep Med; 2006 Jun; 7(4):312-8. PubMed ID: 16709464
[TBL] [Abstract][Full Text] [Related]
19. Effect of valerian on sleep quality in postmenopausal women: a randomized placebo-controlled clinical trial.
Taavoni S; Ekbatani N; Kashaniyan M; Haghani H
Menopause; 2011 Sep; 18(9):951-5. PubMed ID: 21775910
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of zolpidem extended release in elderly primary insomnia patients.
Walsh JK; Soubrane C; Roth T
Am J Geriatr Psychiatry; 2008 Jan; 16(1):44-57. PubMed ID: 18165461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
